QSAM Biosciences ROCE
What is the ROCE of QSAM Biosciences?
The ROCE of QSAM Biosciences, Inc. is 427.73%
What is the definition of ROCE?
Return on capital employed (ROCE) is a financial ratio that measures a company’s profitability and the efficiency with which its capital is used.
= EBIT / (assets - current liabilities)
Return on capital employed (ROCE) is the total amount of capital that a company has utilized in order to generate profits. It is the sum of shareholders' equity and debt liabilities. It can be simplified as total assets minus current liabilities.
ROCE is especially useful when comparing the performance of companies in capital-intensive sectors. ROCE considers debt and other liabilities as well compared to other fundamentals which only analyze profitability related to a company’s common equity. This provides a better indication of financial performance for companies with significant debt. For a company, the ROCE trend over the years is also an important indicator of performance. In general, investors tend to favor companies with stable and rising ROCE numbers over companies where ROCE is volatile and bounces around from one year to the next.
Instead of using capital employed at an arbitrary point in time, analysts and investors often calculate ROCE based on the average capital employed (ROACE), which takes the average of opening and closing capital employed for the time period.
ROCE of companies in the Health Care sector on OTC compared to QSAM Biosciences
What does QSAM Biosciences do?
QSAM Biosciences, Inc., a clinical stage biotechnology company, develops drugs for the treatment of bone cancer. The company is involved in the development of CycloSam (Samaium-153 DOTMP), a clinical-stage novel radiopharmaceutical for the treatment of bone cancer and related diseases. It has a license agreement with IGL Pharma, Inc. The company was formerly known as Q2Earth, Inc. and changed its name to QSAM Biosciences, Inc. in September 2020. QSAM Biosciences, Inc. was founded in 2004 and is based in Austin, Texas.
Companies with roce similar to QSAM Biosciences
- PAVmed Inc has ROCE of 411.68%
- Q-Gold Resources has ROCE of 414.05%
- LiteLink Technologies has ROCE of 414.08%
- Empire Industries has ROCE of 418.52%
- 102570 has ROCE of 421.84%
- Capitan Mining has ROCE of 423.79%
- QSAM Biosciences has ROCE of 427.73%
- Mustang Bio Inc has ROCE of 433.01%
- Sonoro Gold has ROCE of 434.69%
- Nevtah Capital Management has ROCE of 448.86%
- Richland Resources International has ROCE of 448.86%
- Permian Basin Royalty Trust has ROCE of 457.43%
- Navigator Acquisition has ROCE of 463.12%